Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
This article explains which coins beginners should consider for long term holding, emphasizing diversification and prudent risk.
28,247 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Rising tensions over Iran push oil prices higher as speculative traders flood a 24/7 crypto platform offering perpetu...
Oil markets may stay tight for years. This guide explains why and highlights two energy stocks that fit a higher-for-...
A market strategist argues the AI urge to spend is cooling, transferring momentum from software giants to chipmakers ...
Seven U.S. spot XRP ETFs have drawn $1.44B since late 2025, but XRP’s price remains volatile as inflows outpace gains.
Dell Technologies surged 248% from year-end 2025 to midsummer 2026, sparking a parallel rally in the IGPT AI ETF. Thi...
Two Nevada lawmakers demand a comprehensive plan to fix safety oversight gaps tied to Elon Musk's Boring Co. tunnelin...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
RAD Intel debuts a Regulation A+ offering at $0.91 per share, pitching an AI-driven marketing engine as the next oppo...
Cerebras Systems’ IPO surge has cooled, steering investors toward Alibaba as a more scalable AI platform. This report...
Most income investors have long searched for steady monthly cash flow, and these NASDAQ-focused ETFs offer a new appr...
NVDY is pursuing income by selling Nvidia’s strongest move days, financing a roughly 60% distribution. The strategy b...